Opinion: Cannabis companies should file amended tax returns to claim 280E refunds

Two legal cases have realistic chances of success, meaning cannabis operators should consider filing amended federal tax returns claiming refunds.

DOJ asks judge to dismiss federal marijuana prohibition challenge

U.S. Department of Justice attorneys asked a federal judge on Tuesday to dismiss a lawsuit filed by four marijuana companies challenging federal prohibition.

Rescheduling could change how medical practitioners do business: Q&A with marijuana health pros

Here’s how marijuana rescheduling could impact medical practitioners working in the cannabis space.

Marijuana rescheduling doesn’t open door to Big Pharma takeover, report says

The Biden administration’s push to reclassify marijuana under federal law would not by itself open the door for pharmaceutical companies to seize control of the $34 billion legal U.S. cannabis industry.

Feds weighed state-regulated MMJ programs, compared marijuana to alcohol in rescheduling recommendation

State-regulated medical cannabis programs and illicit users are at least in part to thank for the Biden administration’s recommendation that marijuana be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act.

Unsealed rescheduling letter: Marijuana less harmful than other drugs

The Biden administration on late Friday released the unredacted exchange between federal authorities recommending marijuana be rescheduled.

State attorneys general urge DEA to reschedule marijuana

Attorneys general from 12 states sent a letter to the head of the U.S. Drug Enforcement Administration to “encourage” the DEA to reschedule marijuana.

Opinion: What marijuana investors should watch for in the year ahead

From legislative and regulatory changes to market sensitivity and price stabilization to M&A dynamics, it will be crucial to remain cautious of hurdles that the marijuana sector will face and stay on top of the five areas that are expected to shape the industry in 2024.

DEA confirms it is reviewing marijuana rescheduling recommendation

The U.S. Drug Enforcement Administration is currently “conducting its review” of an earlier recommendation that the agency reschedule marijuana, a DEA official recently told a federal lawmaker.

Rescheduling marijuana and the next states to legalize: 7 predictions for 2024

MJBizDaily offers up seven predictions for the U.S. cannabis industry in 2024, including the rescheduling of marijuana.

Opinion: Will Year of the Dragon breathe fire into the marijuana market in 2024?

Here are eight predictions for trends that could most likely impact state-regulated marijuana markets in 2024.

Interstate cannabis sales put California at risk of federal enforcement, AG says

A letter from California Attorney General Rob Bonta to state regulators all but ended marijuana industry hopes of interstate cannabis commerce.